[ad_1]
The Global Fund to Fight AIDS, Tuberculosis and Malaria has signed multi-year framework agreements with HIV drug providers that will save $ 324 million by the end of the year of 2021 and guarantee the safety of more than 4 million people. 19659002] Framework agreements, involving 14 pharmaceutical companies, build an expanded base of suppliers and ensure cost competitiveness and security of supply, essential elements in the expansion of HIV treatment in a way that more reliable and more profitable. Contracts for antiretroviral drugs total US $ 1.2 billion over the next four years.
"These agreements are a strategically smart and highly effective way to ensure greater volumes of life-saving medicines," said Peter Sands. . "In a complex high-volume business, it is a performance-based approach that reduces risk and obtains essential HIV drugs at the most competitive prices, with consistency and reliability."
antiretroviral drugs, including a shorter product life cycle, increased competition and the availability of active pharmaceutical ingredients. The agreements also seek to maximize the use of newer, more effective and cheaper anti-HIV drugs as soon as they are available.
In recent years, the Global Fund has shifted its supply strategy from a call-to-offer system to a more strategic one. focuses on the performance and effective management of supplier relationships with stricter quality and sustainability criteria. The Global Fund also requires compliance with a code of conduct for suppliers.
In the new framework agreements, the Global Fund is saving money through a judicious balance between cost competitiveness and long-term incentives for suppliers. Suppliers with high performance in delivering products on time and in full can benefit from higher order volumes.
A long-term, performance-based approach to responsible sourcing directly benefits global health partners. Many countries can use national funding for health to leverage the Global Fund's pooled procurement mechanism and the wambo.org online platform, with rigorous benchmarking of prices and best business practices.
The selection of suppliers participating in framework agreements followed a rigorous evaluation process. A technical evaluation committee carefully reviewed the proposals and rated each supplier and each product on technical and commercial criteria, allowing the Global Fund to focus on quality, price, security of supply, On-time delivery capability and overall responsiveness.
.
[ad_2]Source link
